Pressmeddelanden från Magle Chemoswed

Bevaka pressreleaser

Kurs från TradingView

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

Magle Chemoswed

Magle Chemoswed Holding AB enters into exclusive license agreement for amniotic stem cell technology 18 feb 18:00

Magle Chemoswed

Magle Group Issues Profit Warning Ahead of Q4 and Full-Year 2025 Results 29 jan 11:18

Magle Chemoswed

Magle Group Announces Strategic Refocus to Strengthen Profitability and Operational Discipline 21 jan 13:52

Magle Chemoswed

Magle Group Announces Planned Transition in Chief Operating Officer Role 02 jan 13:03

Magle Chemoswed

Magle Group today announces a change in executive leadership 16 dec 2025 13:33

Magle Chemoswed

Magle Chemoswed Holding AB announces change of Certified Adviser to Redeye 01 dec 2025 15:00

Magle Chemoswed

Magle Group Enters Strategic Distribution Agreement with Rifa Pharma for SmartPAN® and SmartGEL® in India.27 nov 2025 08:30

Magle Chemoswed

Magle Chemoswed Holding Announces Chairman Transition 17 nov 2025 14:53

Magle Chemoswed

Magle Group Completes European Medical Device Filing for the Use of EmboCept® S in Genicular Artery Embolisation 14 nov 2025 08:30

Magle Chemoswed

Magle Chemoswed Holding Reports Financial Results For Third Quarter 2025 31 okt 2025 08:30

Magle Chemoswed

Magle Group Announces Revised Publication Date for Q3 2025 Due to Ongoing Consolidation Processes 23 okt 2025 15:25

Magle Chemoswed

Magle Group sponsors inaugural VENTI Conference in Tokyo, Japan — supporting innovation in vascular embolotherapy and pain interventions 22 okt 2025 08:56

Magle Chemoswed

Magle Biopolymers receives 2026 order showing a material increase in demand for one of its proprietary dextran derivatives 20 okt 2025 10:40

Magle Chemoswed

Magle Group announces positive clinical evidence review of EmboCept® S for Genicular Artery Embolisation (GAE); regulatory filing in Europe now in preparation 02 okt 2025 07:45

Magle Chemoswed

Magle Group Secures Registration of SmartPAN® in Singapore, Enabling Launch in Pancreatic Surgery 01 aug 2025 07:30

Magle Chemoswed

Magle Chemoswed Holding Reports Financial Results For Second Quarter 2025 29 jul 2025 09:00

Magle Chemoswed

Magle Group’s financial results for the second quarter anticipated to fall short of market expectations.24 jun 2025 17:20

Magle Chemoswed

Magle Group successfully places senior secured bonds of SEK 350 million 13 jun 2025 07:30

Magle Chemoswed

Magle Group contemplates issuance of senior secured bonds 05 jun 2025 17:54

Magle Chemoswed

The acquisition of all shares in Saving Chlora AB has been completed 26 maj 2025 15:00

Magle Chemoswed

Kommuniké från årsstämma i Magle Chemoswed Holding AB (publ) den 26 maj 5 22 maj 2025 09:56

Magle Chemoswed

Magle Chemoswed Holding Reports Financial Results For First Quarter 2025 05 maj 2025 17:30

Magle Chemoswed

Magle Chemoswed Holding AB (publ) Releases Annual Report for 2024.27 apr 2025 18:30

Magle Chemoswed

Malmö, Sweden – Magle Group announces a revised publication date for its 2024 Annual Report, and its Q1 2025 Interim Report.25 apr 2025 16:30

Magle Chemoswed

Correction: Magle Chemoswed Holding Reports Financial Results For Fourth Quarter 2024 25 apr 2025 09:00

Magle Chemoswed

Magle PharmaCept Partners with Pancreatic Cancer Europe PCE to Advance Innovation in Pancreatic Cancer Care 24 apr 2025 11:15

Magle Chemoswed

Magle Group Announces Acquisition of Saving Chlora AB 24 apr 2025 09:00

Magle Chemoswed

Kallelse till årsstämma i Magle Chemoswed Holding AB (publ)28 mar 2025 14:35

Magle Chemoswed

Magle Group till BioStock: We live by the mantra ‘earn it before you burn it’28 mar 2025 14:35

Magle Chemoswed

Magle Group to BioStock: We live by the mantra ‘earn it before you burn it’27 mar 2025 08:30

Magle Chemoswed

Magle Chemoswed Holding Reports Financial Results For Fourth Quarter 2024 24 mar 2025 12:35

Magle Chemoswed

BioStock: Magle Group launches multicenter trial with pancreatic leakage indicator 19 mar 2025 08:15

Magle Chemoswed

Magle Group initiates Randomized Controlled Multicenter Trial with leading European university hospitals to explore SmartPAN® efficacy 26 feb 2025 18:00

Magle Chemoswed

Ingela Fritzson resigns from the Board of Directors of Magle Group 17 feb 2025 09:00

Magle Chemoswed

Magle Group is pleased to announce Magle PharmaCept’s participation in the DPC, German Pancreatic Club congress, set to take place February 27-March 1, 2025, in Heidelberg, Germany.14 feb 2025 08:05

Magle Chemoswed

Magle Group Announces Revised Publication Date for Q4 2024 and Full-Year 2024 Reports Due to Ongoing Consolidation Process 09 jan 2025 21:45

Magle Chemoswed

Magle Group offentliggör tilldelning i den riktade emissionen 30 dec 2024 12:30

Magle Chemoswed

Kommuniké från extra bolagsstämma i Magle Chemoswed Holding AB 20 dec 2024 15:30

Magle Chemoswed

Magle Group tillförs cirka 36,8 MSEK i företrädesemissionen 16 dec 2024 15:30

Magle Chemoswed

Magle Group offentliggör tilläggsprospekt 16 dec 2024 10:40

Magle Chemoswed

Magle Group Approves Multi-Centre Clinical Trial in Genicular Artery Embolisation for Osteoarthritis Pain Relief 12 dec 2024 22:45

Magle Chemoswed

Kallelse till extra bolagsstämma i Magle Chemoswed Holding AB (publ)12 dec 2024 22:00

Magle Chemoswed

Magle Group beslutar om en villkorad riktad nyemission om upp till cirka 26,6 MSEK 10 dec 2024 18:00

Magle Chemoswed

Magle Group offentliggör tilläggsprospekt 05 dec 2024 08:50

Magle Chemoswed

Appointment of Aaron Wong as CFO of Magle Group 05 dec 2024 08:50

Magle Chemoswed

Announcement of CFO Petra Jönsson Sjölin’s Resignation 04 dec 2024 13:00

Magle Chemoswed

Correction: Nomination Committee appointed for the annual general meeting 2025 in Magle Chemoswed Holding 03 dec 2024 11:30

Magle Chemoswed

Nomination Committee appointed for the Annual General Meeting 2025 in Magle Chemoswed Holding 02 dec 2024 17:30

Magle Chemoswed

Magle Group offentliggör prospekt avseende företrädesemissionen 22 nov 2024 08:30

Magle Chemoswed

Magle Group beslutar om företrädesemission om cirka 36,8 MSEK 24 okt 2024 08:30

Magle Chemoswed

Magle Chemoswed Holding Reports Financial Results For Third Quarter 2024 07 okt 2024 11:45

Magle Chemoswed

Fusionen mellan Magle Group och Amniotics är slutförd 04 okt 2024 16:00

Magle Chemoswed

Kvittningsemissionen till PRS1 ApS är genomförd 04 okt 2024 11:00

Magle Chemoswed

Kommuniké från extra bolagsstämma i Magle Chemoswed Holding AB 04 okt 2024 09:00

Magle Chemoswed

Magle Group beslutar om emission av vederlagsaktier 02 okt 2024 09:00

Magle Chemoswed

Magle Chemoswed and I2Pure Announce Joint Venture in Wound Care 23 sep 2024 13:30

Magle Chemoswed

Bolagsverket har lämnat tillstånd att verkställa fusionsplanen mellan Magle Group och Amniotics 18 sep 2024 09:15

Magle Chemoswed

Kallelse till extra bolagsstämma i Magle Chemoswed Holding AB (publ)21 aug 2024 09:30

Magle Chemoswed

BioStock: How Magle Group focus their use of DSM 18 jul 2024 14:58

Magle Chemoswed

BioStock: Magle Group ger en halvårsöversikt och blickar framåt 18 jul 2024 08:30

Magle Chemoswed

Magle Chemoswed Holding Reports Financial Results For Second Quarter 2024 01 jul 2024 17:30

Magle Chemoswed

Magle Group offentliggör fusionsdokument avseende fusionen med Amniotics 01 jul 2024 14:00

Magle Chemoswed

Förvärvet av aktierna i pK Biotech ApS och pK Chemicals A/S har genomförts 28 jun 2024 08:45

Magle Chemoswed

Magle Group ingår samgåendeavtal avseende förvärvet av pK Biotech ApS och pK Chemicals A/S 20 jun 2024 08:15

Magle Chemoswed

BioStock: Magle Group tar hand om helheten inom CDMO 19 jun 2024 09:17

Magle Chemoswed

BioStock: Magle Group visar framfötterna 17 jun 2024 08:00

Magle Chemoswed

Magle Group offentliggör förvärv av pK Biotech ApS och pK Chemicals A/S 30 maj 2024 20:00

Magle Chemoswed

Magle Group och Amniotics går samman och skapar en ledande aktör inom högkvalitativa, livsförändrande hälsoinnovationer med ett breddat CDMO-erbjudande 20 maj 2024 23:30

Magle Chemoswed

Magle Group fullföljer inte det offentliga uppköpserbjudandet till aktieägarna i Amniotics 07 maj 2024 16:50

Magle Chemoswed

MAGLE GROUP REDOVISAR UTFALL OCH FÖRLÄNGER ACCEPTPERIODEN FÖR DET OFFENTLIGA UPPKÖPSERBJUDANDET TILL AKTIEÄGARNA I AMNIOTICS 25 apr 2024 13:30

Magle Chemoswed

Kommuniké från årsstämma i Magle Chemoswed Holding AB (publ) den 25 april 2024 18 apr 2024 08:30

Magle Chemoswed

Magle Chemoswed Holding Reports Financial Results For First Quarter 2024 05 apr 2024 08:30

Magle Chemoswed

Magle Chemoswed Holding AB offentliggör erbjudandehandling och meddelar uppdaterad tidplan avseende kontanterbjudandet till aktieägarna i Amniotics AB 26 mar 2024 08:30

Magle Chemoswed

Magle Chemoswed Holding AB (publ) Releases Annual Report for 2023.25 mar 2024 09:00

Magle Chemoswed

KALLELSE TILL ÅRSSTÄMMA I MAGLE CHEMOSWED HOLDING AB (PUBL)22 mar 2024 14:00

Magle Chemoswed

Magle Chemoswed Holding AB (publ) withdraws dividend proposal and enters into term loan facilities amounting to SEK 12 million in total 22 mar 2024 07:30

Magle Chemoswed

Magle Chemoswed Holding AB lämnar ett rekommenderat kontanterbjudande om 0,004 kronor per aktie till aktieägarna i Amniotics AB 16 feb 2024 08:30

Magle Chemoswed

Magle Chemoswed Holding AB (PUBL) – Publishes Full Year Report 2023 and Board’s Initial Proposal for Paying Dividends 25 okt 2023 08:30

Magle Chemoswed

Magle Chemoswed Holding Reports Financial Results For Third Quarter 2023 08 sep 2023 16:05

Magle Chemoswed

Magle Group enters collaboration with Sirtex Medical to support the international commercialization of EmboCept® S DSM 50 µm 18 jul 2023 08:30

Magle Chemoswed

Magle Chemoswed Holding Reports Financial Results For Second Quarter 2023 24 maj 2023 14:30

Magle Chemoswed

Magle Group applies for extended patent protection of its DSM technology in Europe 27 apr 2023 17:00

Magle Chemoswed

Magle Group’s CEO purchases shares from board member 27 apr 2023 08:30

Magle Chemoswed

Positive results from post-market clinical follow-up of Magle Group’s innovative medical device SmartPAN® presented at scientific congress 26 apr 2023 13:30

Magle Chemoswed

Kommuniké från årsstämma i Magle Chemoswed Holding AB (publ) den 26 april 2023 19 apr 2023 08:30

Magle Chemoswed

Magle Chemoswed Holding Reports Financial Results For First Quarter 2023 29 mar 2023 15:55

Magle Chemoswed

Magle Chemoswed Holding AB (publ) Releases Annual Report for 2022.24 mar 2023 10:00

Magle Chemoswed

KALLELSE TILL ÅRSSTÄMMA I MAGLE CHEMOSWED HOLDING AB (PUBL)16 feb 2023 08:00

Magle Chemoswed

Magle Chemsowed Holding AB (PUBL) – PUBLISHES FULL YEAR REPORT 2022 21 nov 2022 09:30

Magle Chemoswed

Magle Group’s proprietary product AXXO® Woundgel receives regulatory approval in Kuwait 17 nov 2022 12:30

Magle Chemoswed

Magle Group’s vascular embolic product Embocept® S receives regulatory approval in Argentina 09 nov 2022 08:29

Magle Chemoswed

Magle Chemoswed Holding Reports Financial Results For Third Quarter 2022 02 nov 2022 16:30

Magle Chemoswed

Invitation to presentation of Magle Group’s report for Q3 2022 04 okt 2022 16:30

Magle Chemoswed

Magle Chemoswed Holding AB announces change of Certified Adviser to Vator Securities 12 sep 2022 08:50

Magle Chemoswed

Magle Group appoints new Chief Marketing and Innovation Officer 17 aug 2022 08:00

Magle Chemoswed

Magle Chemoswed Holding Reports Financial Results For First Half year 2022 16 aug 2022 16:50

Magle Chemoswed

Magle Chemoswed Holding AB announces the resignation of Julia Kamber Rouhi from the Board of Directors of Magle Chemoswed Holding.11 aug 2022 12:43

Magle Chemoswed

Invitation to presentation of Magle Chemoswed’s report for Q2 2022 11 jul 2022 13:00

Magle Chemoswed

First patients enrolled in a post-market study of Magle Group’s innovative medical device SmartPAN®18 maj 2022 09:00

Magle Chemoswed

Magle Group announces innovation sponsorship with leading life science incubator in Sweden